Sawa; Akira
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sawa; Akira.The latest application filed is for "novel methodology to identify biomarkers relevant to neurons in the brain by using non-invasive nasal biopsy".
- Sawa; Akira - Baltimore MD
| Patent | Date |
|---|---|
| GAPDH cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness Grant 10,292,980 - Sawa , et al. | 2019-05-21 |
| Novel Methodology To Identify Biomarkers Relevant To Neurons In The Brain By Using Non-invasive Nasal Biopsy App 20190078149 - Sawa; Akira ; et al. | 2019-03-14 |
| Gapdh Cascade Inhibitor Compounds And Methods Of Use And Treatment Of Stress Induced Disorders Including Mental Illness App 20170087145 - Sawa; Akira ; et al. | 2017-03-30 |
| Gapdh Cascade Inhibitor Compounds And Methods Of Use And Treatment Of Stress Induced Disorders Including Mental Illness App 20150218103 - Sawa; Akira ; et al. | 2015-08-06 |
| Method for diagnosing or predicting susceptibility to psychiatric disorders Grant 7,491,499 - Sawa February 17, 2 | 2009-02-17 |
| Method for diagnosing or predicting susceptibility to psychiatric disorders App 20050255500 - Sawa, Akira | 2005-11-17 |
| NCAGE Code | 4UX30 | SAWA,AKIRA |
| CAGE Code | 4UX30 | SAWA,AKIRA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 